The company said, “RXO expects third-quarter 2025 adjusted EBITDA to be between $33 million and $43 million. In Brokerage, the company expects overall volume growth to be approximately flat year-over-year and gross margin to be between 13.5% and 15.0% in the third quarter.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target raised to $20 from $18 at Truist
- RXO Inc. price target lowered to $14 from $15 at JPMorgan
- RXO Inc. price target lowered to $21 from $23 at Morgan Stanley
- RXO, Inc. Faces Mixed Performance and Regulatory Challenges: Hold Rating with Cautious Outlook
- RXO Inc. price target raised to $12 from $10 at Susquehanna